Innate Immune Function of Neutrophil Cytoplasts Generated Post-Vital NETosis

The migration of polymorphonuclear neutrophils (PMN) into the site of infection such as lungs during pneumonia is a canonical feature of innate immunity. Formation of neutrophil-derived extracellular traps (NETs), web-like strands of varying lengths comprising DNA, histones, elastase, and myeloperoxidase, is an important determinant of PMN-mediated innate immunity. NETs form in microvessels, entrap bacteria and effete matter, and dampen PMN-mediated inflammatory injury at specific sites. However, studies have largely focused on NET release secondary to lytic NETosis and lysis of PMN. Far less is known about vital NETosis occurring in the absence of PMN rupture. As vital NETosis is characterized by generation of anuclear PMN termed cytoplasts (PMNcyto), we addressed the function of PMNcyto as a critical determinant of PMN-mediated innate immunity. Studies were made in mice challenged with live Pseudomonas aeruginosa (PA) i.t. to induce fulminant pneumonia characterized by tissue injury in which we determined the role of generated PMNcyto population. Using Tomato Red (tDTomato) transgenic mice to mark PMN, we observed PA pneumonia induced PMN transmigration leading to PMNcyto generation in the airspace. In contrast, PMNcyto transmigration, was minimal. PMNcyto accumulating in lung tissue actively phagocytosed and killed PA. Instillation of ex vivo generated PMNcyto also prevented PA-induced inflammatory lung injury and reduced mortality as compared to control mice. We demonstrated that the salutary effects of PMNcyto required functional microchondria. Proteomic analysis revealed that PMNcyto retained bactericidal and ROS generating pathways, consistent with an intact plasma membrane. Genetic deletion of peptidyl arginine deaminase 4 (PAD4), which mediates histone citrullination and promotes NETosis, facilitates PMNcyto generation and thereby abrogated pneumonia-induced mortality. Thus, we have identified the crucial host defense function of PMNcyto generated post-vital NETosis, suggesting that PMNcyto hold promise as cell based anti-bacterial therapy in pneumonia.